4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001214659-19-005387
CEO and President bought 8,000 shares at an average $3.87 ($30,987)
From the SEC's structured data for this filing
Trades in this filing
Kendall Keith J · CEO and President
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-09 | Purchase : show line 1 in the form | +2,000 | $3.84 | $7,680 | 648,581 | D |
| 2019-08-09 | Purchase : show line 2 in the form | +1,000 | $3.93 | $3,925 | 649,581 | D |
| 2019-08-09 | Purchase : show line 3 in the form | +2,000 | $4.00 | $7,990 | 651,581 | D |
| 2019-08-13 | Purchase : show line 4 in the form | +1,000 | $4.05 | $4,045 | 652,581 | D |
| 2019-08-14 | Purchase : show line 5 in the form | +1,000 | $3.70 | $3,697 | 653,581 | D |
| 2019-08-14 | Purchase : show line 6 in the form | +1,000 | $3.65 | $3,650 | 654,581 | D |
| Open-market purchases · 8,000 sh · avg $3.87 · $30,987 | ||||||
Loading xslF345X03/marketforms-45524.xml…